University of British Columbia (Rights of Synthetic Psilocybin Research) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
University of British Columbia (Rights of Synthetic Psilocybin Research) General Information
Description
Rights of provisional patent application related to the development of scalable synthetic psilocybin and other tryptamine compounds in Vancouver, Canada.
Contact Information
Corporate Office
- Vancouver, British Columbia
- Canada
Corporate Office
- Vancouver, British Columbia
- Canada
University of British Columbia (Rights of Synthetic Psilocybin Research) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
University of British Columbia (Rights of Synthetic Psilocybin Research) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
University of British Columbia (Rights of Synthetic Psilocybin Research) FAQs
-
Where is University of British Columbia (Rights of Synthetic Psilocybin Research) headquartered?
University of British Columbia (Rights of Synthetic Psilocybin Research) is headquartered in Vancouver, Canada.
-
What industry is University of British Columbia (Rights of Synthetic Psilocybin Research) in?
University of British Columbia (Rights of Synthetic Psilocybin Research)’s primary industry is Buildings and Property.
-
Is University of British Columbia (Rights of Synthetic Psilocybin Research) a private or public company?
University of British Columbia (Rights of Synthetic Psilocybin Research) is a Private company.
-
What is the current valuation of University of British Columbia (Rights of Synthetic Psilocybin Research)?
The current valuation of University of British Columbia (Rights of Synthetic Psilocybin Research) is .
-
What is University of British Columbia (Rights of Synthetic Psilocybin Research)’s current revenue?
The current revenue for University of British Columbia (Rights of Synthetic Psilocybin Research) is .
-
Who are University of British Columbia (Rights of Synthetic Psilocybin Research)’s investors?
The University of British Columbia has invested in University of British Columbia (Rights of Synthetic Psilocybin Research).
-
When was University of British Columbia (Rights of Synthetic Psilocybin Research) acquired?
University of British Columbia (Rights of Synthetic Psilocybin Research) was acquired on 21-Nov-2021.
-
Who acquired University of British Columbia (Rights of Synthetic Psilocybin Research)?
University of British Columbia (Rights of Synthetic Psilocybin Research) was acquired by Telescope Innovations.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process